• Home
  • Search Results

Search Results

Cancer
Cancer - Lymphoma
Cancer - Multiple Myeloma
Young Adult (18-34)
Adult (35-64)
Older Adult (65+)
Open
32 studies match your search
Open

CAR-T cells targeting the kappa antigen for Relapsed/ Refractory mantle cell and indolent non-Hodgkin lymphomas

Do you have mantle cell lymphoma or other non-Hodgkin lymphoma that has either come back or did not get better with your last treatment? If so, you may be able to take part in a study that will modify your own immune cells to see if it may treat your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female
Study Interest
  • Cancer (Lymphoma)
Open

Study of Acalabrutinib in Relapsed/Refractory CNS Lymphomas

Have you been diagnosed with central nervous system (CNS) lymphoma? Have you received treatment for this disease, but it either came back or did not improve? Then you may be eligible to participate ind a study to look at the safety and effectiveness of the new study drug acalabrutinib.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

A Study of Belantamab Mafodotin (GSK2857916) in Multiple Myeloma Participants with Normal and Impaired Kidney Function

Have you been diagnosed with multiple myeloma? If so, you may be able to take part in a research study looking at the safety of giving a new drug called Belantamab Mafodotin to patients with multiple myeloma and normal or impaired kidney function.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

The HealthScore Health Coaching Program

Are you living with Metastatic or Advanced Cancer? Are you interested in having a personal health coach to help you set healthy lifestyle goals? Your personal health coach would prescribe cardio and strength training exercises, help you monitor symptoms, and navigate you to supportive care. If you have cancer and are receiving care at UNC Cancer Center, you may be able to participate.

Age & Gender
  • 15 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Behavior
  • Chronic Conditions
  • Mental and Emotional Health
  • and 4 more
Visit Location
100% Remote (online, phone, text)
Open

Daratumumab/rHuPh20 +/- Lenalidomide as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Do you have multiple myeloma? Have you had a stem cell transplant? If so, you may be able to take part in a research study looking at the effectiveness of giving a drug called daratumumab, along with lenalidomide, after a stem cell transplant to patients with multiple myeloma.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
  • Transplant
Open

Phase II Study of CD30 CAR for relapsed/refractory CD30+ T Cell Lymphoma

Do you have Peripheral T Cell Lymphoma? Has your cancer come back or did it not get better with the last treatment you were given? If so, you may be eligible to participate in this gene therapy research study to learn more about using your own modified immune cells as possible treatment.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

PD-1 blocker and gene therapy study for patients with Hodgkin Lymphoma

Do you have Hodgkin's Lymphoma that has either come back or did not get better after CAR-T therapy? If so, you may be able to take part in a study that will use anti-PD-1 therapy to treat your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

PERMIT - PERsonalized BioMarkers for Immunotherapy Treatment

Have you been diagnosed with multiple myeloma or high-risk smoldering multiple myeloma? If so, you may be able to take part in a research study looking at how drugs used to treat multiple myeloma work.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Blood Conditions
  • Cancer (Multiple Myeloma)
Open

CD19 CAR T-cells containing a Safety Switch to Treat Relapsed/Refractory B-cell Lymphoma

Have you been diagnosed with B-Cell Lymphoma? Are you looking for options to treat your cancer? If so, you may be able to take part in a research study looking at the safety of giving a new drug called iC9-CAR19 with Rimiducid.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Lymphoma)
Open

Study of ATLCAR.CD138 cells for relapsed/refractory Multiple Myeloma

Have you been diagnosed with Relapsed/Refractory Multiple Myeloma? You may be able to take part in a gene transfer research study that uses your own modified immune cells to see if it is effective in treating your cancer.

Age & Gender
  • 18 years ~ 99 years
  • Male, Female, Gender Inclusive
Study Interest
  • Cancer (Multiple Myeloma)
Research for Me logo

Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH.  This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.

Questions?

  • This email address is being protected from spambots. You need JavaScript enabled to view it.
logo for the North Carolina Translational and Clinical Sciences Institute
logo for UNC Health
logo for UNC School of Medicine
logo for UNC Research